Bionovate Competitors

BIIO Stock  USD 0.0001  0.00  0.00%   
Analyzing Bionovate Technologies competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Bionovate Technologies to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Bionovate Technologies Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Bionovate Technologies competition on your existing holdings.
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.000.00010.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.0000840.00
Details
Naive
Forecast
LowNextHigh
0.00010.00010.0001
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00010.00010.0001
Details

Bionovate Technologies Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Bionovate Technologies and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Bionovate and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Bionovate Technologies does not affect the price movement of the other competitor.

High positive correlations

PROTMMTC
PJETMMTC
ROSGQMMTC
AMHDMMTC
PJETPROT
ROSGQPROT
  

High negative correlations

ATRXMOTS
UTRSATRX
LITHATRX
LITHMOTS
AMHDLITH
LITHROSGQ

Risk-Adjusted Indicators

There is a big difference between Bionovate Stock performing well and Bionovate Technologies Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bionovate Technologies' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
MMTC  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
MOTS  34.85  16.99  0.00 (3.80) 0.00 
 0.00 
 1,050 
PROT  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
PJET  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
ATRX  2.95 (1.49) 0.00  5.81  0.00 
 0.00 
 99.00 
UTRS  27.33  11.89  0.00 (15.15) 0.00 
 0.00 
 980.00 
ROSGQ  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
LITH  3.01  0.73  0.00  2.98  0.00 
 0.00 
 100.00 
AMHD  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 

Bionovate Technologies Competitive Analysis

The better you understand Bionovate Technologies competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Bionovate Technologies' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Bionovate Technologies' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
BIIO MMTC MOTS PROT PJET ATRX UTRS ROSGQ LITH AMHD
 0.00 
 0.0001 
Bionovate
 0.00 
 0.0001 
Micro
 0.00 
 0.0001 
Motus
 0.00 
 0.0001 
Proteonomix
 0.00 
 0.0001 
Priority
 0.00 
 0.0001 
Adhera
 50.00 
 0.0001 
Minerva
 0.00 
 0.0001 
Rosetta
 50.00 
 0.0001 
LITH
 0.00 
 0.0002 
HLK
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Current Valuation
Operating Margin
Price To Book
Retained Earnings
Current Asset
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Total Debt
Return On Equity
Z Score
Book Value Per Share
Return On Asset
Number Of Shares Shorted
Current Liabilities
Total Asset
Debt To Equity
Short Ratio
Target Price
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Relative Strength Index
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Standard Deviation
Kurtosis
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Information Ratio

Bionovate Technologies Competition Performance Charts

Five steps to successful analysis of Bionovate Technologies Competition

Bionovate Technologies' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Bionovate Technologies in relation to its competition. Bionovate Technologies' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Bionovate Technologies in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Bionovate Technologies' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Bionovate Technologies, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Bionovate Technologies position

In addition to having Bionovate Technologies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run ESG Investing Thematic Idea Now

ESG Investing
ESG Investing Theme
Sustainable investments that promote the conservation of the natural world, social resposibility, freindly employees policies and strong governance. The ESG Investing theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize ESG Investing Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Bionovate Technologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bionovate Technologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bionovate Technologies Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bionovate Technologies Corp Stock:
Check out Bionovate Technologies Correlation with its peers.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bionovate Technologies. If investors know Bionovate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bionovate Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bionovate Technologies is measured differently than its book value, which is the value of Bionovate that is recorded on the company's balance sheet. Investors also form their own opinion of Bionovate Technologies' value that differs from its market value or its book value, called intrinsic value, which is Bionovate Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bionovate Technologies' market value can be influenced by many factors that don't directly affect Bionovate Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bionovate Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bionovate Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bionovate Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.